ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) has earned a consensus recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports ...
Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved ...
In trading on Friday, shares of ARS Pharmaceuticals Inc (Symbol: SPRY) crossed below their 200 day moving average of $11.90, changing hands as low as $11.89 per share. ARS Pharmaceuticals Inc ...
Highlights,ARS Pharmaceuticals (SPRY) has received favorable market target projections from research experts.,Significant ...
After hours: 8 January at 6:29:23 pm GMT-5 ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
But the fact that DOGE aides are reportedly working in the offices of Medicaid and even Medicare—where budget cuts have been ...
Revelation Pharma, a leading nationwide network of 503A and 503B compounding pharmacies, has promoted regulatory expert Nancy Fingerhut to Vice President of Quality Assurance and Regulatory Affairs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback